Ireland
--:--IST
Latest
Clinical Trials in France / NCT06952829
Starting soon Not applicable

Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access

NCT06952829 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-04-21
Last updated
2025-05-01

Condition(s) studied

Internal MedicineSurgeryNeurology

Investigational drug(s) / intervention(s)

evaluation of intravenous access of patients with Adult-Difficult IntraVenous Access (A-DIVA) score prior to puncturing subjectevaluation of intravenous access of patients with modified Adult-Difficult IntraVenous access(A-DIVA modified) score prior to puncturing subject

evaluation of intravenous access of patients with Adult-Difficult IntraVenous Access (A-DIVA) score prior to puncturing subject: The patient's intravenous access will be evaluated using the A-DIVA score by the study nurse at the time of admission, prior to venipuncture performed by the care nurse

evaluation of intravenous access of patients with modified Adult-Difficult IntraVenous access(A-DIVA modified) score prior to puncturing subject: The patient's intravenous access will be evaluated using the A-DIVA-m score by the study nurse at the time of admission, prior to venipuncture performed by the care nurse

Study summary

In certain cases (e.g.: patient who are difficult to perfuse, thin veins, etc.), an increase in venipunctures performed by study nurses in healthcare services can lead to a loss of venous capital, repeated pain during punctures, discontinuous treatment follow-up and numerous requests for assistance from colleagues, including nurse anesthetists, but often too late.

The main objective of project is to reduce the number of punctures to access the venous system after evaluation of adult patients upon entering the hospitalization department using the A-DIVA tool. the A-DIVA score predicts the difficulty in infusing an adult patient

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male and Female Adult Patients Aged 18 Years and Older * written informed consent given by patient * Affiliation to a social security system or equivalence system Exclusion Criteria: * Patients in Intensive Care Units * Patients with Psychiatric Disorders or Under Psychiatric Care * Minor Patients Under 18 Years of Age * Pregnant or Breastfeeding Women * Vulnerable and Protected Individuals as Defined by the Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2) * Patients Participating in Another Interventional Study * Dying patients * Patients Receiving Infusions of: * Chemotherapy Drugs with a pH \<5 or \>8 * Solutions with an Osmolarity \>900 mOsm/L * Patients refusing to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHI Robert Ballanger Aulnay-sous-Bois France

More Centre Hospitalier Intercommunal Robert Ballanger trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06952829 on ClinicalTrials.gov ↗ ← All trials in France